--- title: "COMPLANT's subsidiary's major lawsuit first-instance judgment involves nearly 60 million" type: "News" locale: "en" url: "https://longbridge.com/en/news/258650233.md" description: "COMPLANT's subsidiary, Singapore Yade Co., Ltd., has sued Sanmen Dexin Waste Oil Co., Ltd. and Suzhou Shengyuan Environmental Technology Co., Ltd. for unpaid contract payments, with the amount in question nearing 60 million yuan. On September 22, the Sanmen Court issued a first-instance judgment, requiring the defendants to pay the owed amount and interest within one month of the judgment taking effect. The company will closely monitor the progress of the case and disclose relevant information in a timely manner" datetime: "2025-09-24T08:08:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/258650233.md) - [en](https://longbridge.com/en/news/258650233.md) - [zh-HK](https://longbridge.com/zh-HK/news/258650233.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/258650233.md) | [繁體中文](https://longbridge.com/zh-HK/news/258650233.md) # COMPLANT's subsidiary's major lawsuit first-instance judgment involves nearly 60 million In June 2025, the subsidiary of China National Chemical Import & Export Corporation, Singapore Yade Co., Ltd., filed a lawsuit against Sanmen Dexin Waste Oil Co., Ltd. and Suzhou Shengyuan Environmental Technology Co., Ltd. due to unpaid contract payments, involving an amount of 47,725,337.11 yuan in contract arrears and overdue payment interest. On September 22, the Sanmen Court issued a first-instance judgment, requiring the defendants to pay the principal, interest, and costs of realizing the creditor's rights within one month of the judgment taking effect, with the case acceptance fee also to be borne by the defendants. If dissatisfied with the judgment, an appeal may be filed. As the first-instance judgment has not taken effect and been executed, the final impact on the company's profits cannot be determined at this time. The company will closely monitor the progress and disclose timely updates. As of the announcement date, the company has no other significant litigation or arbitration matters that need to be disclosed ### Related Stocks - [COMPLANT (000151.CN)](https://longbridge.com/en/quote/000151.CN.md) ## Related News & Research - [Bank of America Securities Keeps Their Buy Rating on Contemporary Amperex Technology Co., Limited Class H (3750)](https://longbridge.com/en/news/278636079.md) - [Contemporary Amperex Technology plans to issue bonds](https://longbridge.com/en/news/278390266.md) - [FDA Approves Drug Trump Touted for Autism to Treat Other Neurological Disorder](https://longbridge.com/en/news/278577898.md) - [Air India to operate special flights for UAE on March 8 amid Gulf crisis](https://longbridge.com/en/news/278239013.md) - [CATL Announces Final 2025 Dividend and Details Cross-Border Tax Treatment](https://longbridge.com/en/news/278474723.md)